No association between low- and high-activity catecholamine-methyl- transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 3, 2000, Pages 285-288

  Tahir, Eda ^a,b   Curran, Sarah ^b   Yazgan, Yanki ^c   Ozbay, Fatih ^c   Cirakoglu, Beyazit ^c   Asherson, Philip J ^b  

^a SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY   (Turkey)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Association study; Attention deficit hyperactivity disorder (ADHD); Catecholamine methyl transferase (COMT)

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; FAMILY STUDY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; CHILD; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; RISK FACTORS; TANDEM REPEAT SEQUENCES; TURKEY;

EID: 0034640691     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/1096-8628(20000612)96:3<285::AID-AJMG10>3.0.CO;2-D     Document Type: Article

References (35)

1. Achenbach TM. 1991. Manual for the child behavior checklist. Burlington, VT: Department of Psychiatry, University of Vermont.
2. Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Richters JE, Schiller E, Severe JB, Swanson JM, Vereen D, Wells KC. 1997. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children With ADHD (the MTA): design challenges and choices. Arch Gen Psychiatry 54: 865-870.
3. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HHM. 1995. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65:1157-1165.
4. Asghari V, Schoots O, van Kats S, Ohara K, Jovanovic V, Guan HC, Bunzow JR, Petronis A, Van Tol HH. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol 46:364-373, 1994.
5. Biederman J, Faraone SV, Keenan K, et al. 1992. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728-738.
6. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. 1990. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adol Psychiatry 29:526-533.
7. Cantwell DP. 1972. Psychiatric illness in families of hyperactive children. Arch Gen Psychiatry 27:728-738.
8. Conners CK, Barkley RA. 1985. Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 21:1985.
9. Cook JE, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal B. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
10. Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4:192-196.
11. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, Ebstein RP. 1999. Haplotype relative risk study of catechol-o-methyltransferase (COMT) and attention deficit hyperactivity disorders (ADHD): Association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 88(5):497-502.
12. Ewens W, Spielman R. 1995. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 57:455-464.
13. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, Spencer TJ, Wilens TE, Frazier J, Cleves M, Sakai J. 1999. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 156:768-770.
14. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
15. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. 1997. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311-313.
16. Goldman-Rakic PS. 1992. Topography of cognition: parallel distribution networks in primate association cortex. Ann Rev Neurosci 11:137-156.
17. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. 1997. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adol Psychiatry 36:980-988.
18. Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, Weinshilboum RM. 1996. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
19. Lahoste GJ, Swanson JM, Wigal S, Glabe C, Wigal T, King N, Kennedy JL. 1996. Dopamine D4 receptor gene polymorphism is associated with attention-deficit hyperactivity disorder. Mol Psychiatry 1:121-124.
20. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. 1995. Kinetics of human soluble and membrane-bound catechol O- methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
21. Rowe DC, Stever C, Giedinghagen LN, Gard JM, Cleveland HH, Terris ST, Mohr JH, Sherman S, Abramowitz A, Waldman ID. 1998. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 3:419-426.
22. Schaid DJ, Sommer SS. 1993. Genotype relative risks: methods for design and analysis of candidate-gene association studies. Am J Human Genet 53:1114-1126.
23. Schaid DJ, Sommer SS. 1994. Comparison of statistics for candidate gene studies using cases and parents. Am J Human Genet 55:402-409.
24. Shaywitz BA. 1977. CSF amine metabolites in children with minimal brain dysfunction (MBD): evidence of involvement of brain dopamine. J Pediat 90:67-71.
25. Shekim WO, Javaid J, Davis JM, Bylund DB. 1983. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Biol Psychiatry 18:1983.
26. Shen YC, Wang YF. 1984. 3-Methoxy-4-hydroxyphenylglycol sulfate excretion in 73 schoolchildren with minimal brain-dysfunction syndrome. Biol Psychiatry 19:861-870.
27. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del'Homme MA, Asarnow JR, Woodward JA, Ramsey C, Nelson SF. 1998. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 3:427-430.
28. Spielman R, Ewens W. 1996. The TDT and other family-based test for linkage disequilibrium and association. Am J Human Genet 59:983-989.
29. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP. 1998a. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429-433.
30. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S. 1998b. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38-41.
31. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. 1996. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adol Psychiatry 35:1213-1226.
32. Thapar A, Holmes J, Poulton K, Harrington R. 1999. Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 174:105-111.
33. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C. 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Human Genet 63:1767-1776.
34. Waldman ID, Robinson BF, Rhee SH. 1999. A logistic regression extension of the transmission disequilibrium test for continuous traits: application to linkage disequilibrium between alcoholisms and the candidate genes DRD2 and ADH3. Genet Epidemiol 17(Suppl 1):S379-S384.
35. Zametkin AJ, Karoum F, Rapoport JL. 1984. Phenylethylamine excretion in attention deficit disorder. J Am Acad Child Adol Psychiatry 23:310-314.